Search research articles
Contact Us
Filters
Showing results (161-170 of 178) with videos related to
Page
of 18
Sort By:
JAMA Network Open
|
May 5, 2026
Hematopoietic Cell Transplant Access and Patient Diversity
Rachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Transplantation and Cellular Therapy
|
April 21, 2022
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes
Rachel Phelan, Min Chen, Caitrin Bupp, et al.
Transplantation and Cellular Therapy
|
December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
The Journal of Clinical Investigation
|
October 2, 2014
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Jason A Dubovsky, Ryan Flynn, Jing Du, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Frontiers in Immunology
|
September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Transplantation and Cellular Therapy
|
September 30, 2025
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377
Stephen R Spellman, Ke Xu, Temitope Oloyede, et al.
Blood Advances
|
November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study
Andrew S Artz, Brent R Logan, Wael Saber, et al.
Transplantation and Cellular Therapy
|
June 29, 2024
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry
Rachel Cusatis, Carlos Litovich, Zhongyu Feng, et al.
Blood Advances
|
March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704
Mohamed L Sorror, Wael Saber, Brent R Logan, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 178) with videos related to
Sort By:
Page
of 18
JAMA Network Open
|
May 5, 2026
Hematopoietic Cell Transplant Access and Patient Diversity
Rachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Transplantation and Cellular Therapy
|
April 21, 2022
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes
Rachel Phelan, Min Chen, Caitrin Bupp, et al.
Transplantation and Cellular Therapy
|
December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
The Journal of Clinical Investigation
|
October 2, 2014
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Jason A Dubovsky, Ryan Flynn, Jing Du, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Frontiers in Immunology
|
September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Transplantation and Cellular Therapy
|
September 30, 2025
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377
Stephen R Spellman, Ke Xu, Temitope Oloyede, et al.
Blood Advances
|
November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study
Andrew S Artz, Brent R Logan, Wael Saber, et al.
Transplantation and Cellular Therapy
|
June 29, 2024
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry
Rachel Cusatis, Carlos Litovich, Zhongyu Feng, et al.
Blood Advances
|
March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704
Mohamed L Sorror, Wael Saber, Brent R Logan, et al.
Page
of 18